SURFACTANT DEFICIENCY SYNDROME NEONATAL
Clinical trials for SURFACTANT DEFICIENCY SYNDROME NEONATAL explained in plain language.
Never miss a new study
Get alerted when new SURFACTANT DEFICIENCY SYNDROME NEONATAL trials appear
Sign up with your email to follow new studies for SURFACTANT DEFICIENCY SYNDROME NEONATAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gentler lung treatment may help preterm babies avoid breathing tubes
Disease control CompletedThis study looked at 180 premature babies born between 24 and 30 weeks to see if giving lung medication (surfactant) through a thin tube (LISA method) could reduce the need for a breathing tube in the first three days of life, compared to standard CPAP alone. The goal was to find…
Matched conditions: SURFACTANT DEFICIENCY SYNDROME NEONATAL
Phase: NA • Sponsor: Sharp HealthCare • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New pain monitor tested on tiny babies during breathing treatment
Knowledge-focused CompletedThis study tested a new way to measure pain in preterm infants during a procedure called LISA, where surfactant is given to help them breathe. Researchers used skin conductance, which tracks nerve signals, and compared it to a standard pain scale. The goal was to see if this meth…
Matched conditions: SURFACTANT DEFICIENCY SYNDROME NEONATAL
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC